Embody, Inc. Announces $9.3 M Series A Funding Round
Embody, Inc., a privately-held medical device company focused on soft tissue repair, announced that it has closed a $9.3 million Series A funding round with participation from cultivate(MD).
News
Embody Receives $2.5 Million Phase II Research Award
Embody, a cultivate(MD) portfolio company, is receiving a $2.5 million Phase II Small Business Innovation Research award through the Defense Advanced Research Projects Agency (DARPA).
Genesis Innovation Group’s cultivate(MD)™ Capital Fund II, LP Announces Participation in Virtual Incision’s $20 Million Financing to Advance First-of-its-Kind Mini-Robot for General Surgery Abdominal Procedures
HOLLAND, Mich., Jan. 13, 2020 /PRNewswire/ — Genesis Innovation Group’s cultivate(MD) Capital Fund II, LP, a fund focused on investments into early stage healthcare companies with innovative technologies, announces its …
Virtual Incision Announces $20 Million Financing
Virtual Incision, a cultivate(MD) portfolio company, announced today that it has closed announced it has raised $20 million in a Series B+ financing.
Medical Startup Receives FDA Clearance
A medical device startup in the region has received FDA clearance for a new product.
2020 ASAP Meeting
Genesis is proud to be a sponsor of the 2020 ASAP Meeting (Advanced Shoulder ArthroPlasty). This year’s meeting will be held on January 16-18, 2020 in Snowbird, UT.
Shoulder Innovations Announces FDA 510(K) Clearance For Inset Plus™ Augmented Glenoids For Total Shoulder System
HOLLAND, Mich., December 10th, 2019 — Shoulder Innovations, (SI), a leading innovator in the development of shoulder replacement systems, announced today that they have received FDA clearance for their InSet …
Ward Detwiler Named To Crain’s Top 40 Under 40
Congratulations to Ward Detwiler, who was just awarded as a Crain’s Top 40 Under 40!
cultivate(MD) Announces Investment Into Genesis Software Innovations, “GSI”
HOLLAND, Mich., August 20th, 2019– Genesis Innovation Group and their cultivate(MD) Capital Fund II, LP, a fund focused on investments into early stage healthcare companies with innovative technologies, announced their …